The S&P 500's valuation continues to be extended.
I continue to put new money to work in BioXcel Therapeutics and GoHealth.
Here's our technical analysis and trading strategy.
The window the company offered this week on its results and financial state continue to give this value investor pause.
LEVI has done well since our recommendation in early October.
Bids from Western venture capital investors for age-old Japanese names are only likely to increase.
A look at STZ after its latest earnings report.
The thinking is that if the bears can't drag stocks down then it might be time to buy.
An interesting cast of characters share their thoughts on the current market condition and how to act from here.
Let's look at how to play Realogy, the parent of Century 21, Coldwell Banker, Sotheby's International Realty and Better Homes and Gardens Realty.